financetom
Business
financetom
/
Business
/
Merck's cholesterol drug meets main goal in late-stage studies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck's cholesterol drug meets main goal in late-stage studies
Jun 9, 2025 4:17 AM

June 9 (Reuters) - Merck ( MRK ) said on Monday its drug

met the main goal of reducing a type of cholesterol in two

late-stage studies.

(Reporting by Christy Santhosh in Bengaluru; Editing by

Shinjini Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved